Uncoupling of VEGF with endothelial NO as a potential mechanism for abnormal angiogenesis in the diabetic nephropathy (Q38175408)

30 August 2017

12 references

14 March 2019

24 March 2019

19 June 2019

10 October 2019

11 October 2019

4 November 2019

20 November 2019

29 May 2020

20 August 2020

31 August 2020

7 April 2021

13 January 2024

Uncoupling of VEGF with endothelial NO as a potential mechanism for abnormal angiogenesis in the diabetic nephropathy (English)

1 reference

vascular endothelial growth factor A

30 August 2017

0 references

1 reference

10 October 2019

1 reference

11 October 2019

1 reference

4 November 2019

1 reference

20 November 2019

1 reference

20 August 2020

3 references

31 August 2020

7 April 2021

13 January 2024

1 reference

7 April 2021

1 reference

1

Takahiko Nakagawa

1 reference

30 August 2017

Waichi Sato

2

1 reference

PMCID

3872226

30 August 2017

Tomoki Kosugi

series ordinal

3

1 reference

PMCID

3872226

30 August 2017

Richard J Johnson

series ordinal

4

1 reference

30 August 2017

9 December 2013

12 references

Journal of Diabetes Research

30 August 2017

14 March 2019

24 March 2019

19 June 2019

10 October 2019

11 October 2019

4 November 2019

20 November 2019

20 August 2020

31 August 2020

7 April 2021

13 January 2024

12 references

30 August 2017

14 March 2019

24 March 2019

19 June 2019

10 October 2019

11 October 2019

4 November 2019

20 November 2019

20 August 2020

31 August 2020

7 April 2021

13 January 2024

2013

1 reference

30 August 2017

184539

1 reference

Creative Commons Attribution 3.0 Unported

30 August 2017

12 references

14 March 2019

24 March 2019

19 June 2019

10 October 2019

11 October 2019

4 November 2019

20 November 2019

29 May 2020

20 August 2020

31 August 2020

7 April 2021

Reversibility of structural and functional damage in a model of advanced diabetic nephropathy

13 January 2024

0 references

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3872226

Vegfa protects the glomerular microvasculature in diabetes.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3872226

Nicorandil as a novel therapy for advanced diabetic nephropathy in the eNOS-deficient mouse

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3872226

eNOS knockout mice with advanced diabetic nephropathy have less benefit from renin-angiotensin blockade than from aldosterone receptor antagonists

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3872226

Inducible overexpression of sFlt-1 in podocytes ameliorates glomerulopathy in diabetic mice

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3872226

Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3872226

Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3872226

Structural changes in renal arterioles in Type I diabetic patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3872226

Glucose scavenging of nitric oxide

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3872226

Vascular endothelial growth factor receptor-2-mediated mitogenesis is negatively regulated by vascular endothelial growth factor receptor-1 in tumor epithelial cells

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3872226

VEGF(165) mediates glomerular endothelial repair

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3872226

Mortality of type 1 (insulin-dependent) diabetes mellitus in Denmark: a study of relative mortality in 2930 Danish type 1 diabetic patients diagnosed from 1933 to 1972.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3872226

Increased plasma concentration of von Willebrand factor in insulin dependent diabetics with incipient nephropathy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3872226

Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3872226

Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3872226

Selective stimulation of VEGFR2 accelerates progressive renal disease

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3872226

Effect of diabetic duration on serum concentrations of endogenous inhibitor of nitric oxide synthase in patients and rats with diabetes

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3872226

Hyperuricemia induces endothelial dysfunction

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3872226

Features of endothelial dysfunction in early diabetic nephropathy

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3872226

New vessel formation in the renal corpuscles in advanced diabetic glomerulopathy

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3872226

Angiotensin II receptor blockade reduces salt sensitivity of blood pressure through restoration of renal nitric oxide synthesis in patients with diabetic nephropathy

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3872226

The pivotal role of VEGF on glomerular macrophage infiltration in advanced diabetic nephropathy.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3872226

Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3872226

Altered endothelial nitric oxide synthase targeting and conformation and caveolin-1 expression in the diabetic kidney.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3872226

Uncoupling of vascular endothelial growth factor with nitric oxide as a mechanism for diabetic vasculopathy

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3872226

A stereological study of the renal glomerular vasculature in the db/db mouse model of diabetic nephropathy.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3872226

T-786C polymorphism of the endothelial nitric oxide synthase gene is associated with albuminuria in the diabetes heart study

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3872226

Inhibition of vascular endothelial growth factor (VEGF) does not affect early renal changes in a rat model of lean type 2 diabetes.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3872226

Relations between eNOS Glu298Asp polymorphism and progression of diabetic nephropathy

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3872226

Endothelial nitric oxide synthase gene and the development of diabetic nephropathy

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3872226

Hyperglycemic switch from mitochondrial nitric oxide to superoxide production in endothelial cells

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3872226

Association of eNOS Glu298Asp polymorphism with end-stage renal disease

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3872226

Vascular endothelial growth factor is necessary in the development of arteriosclerosis by recruiting/activating monocytes in a rat model of long-term inhibition of nitric oxide synthesis

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3872226

Detection of nitrotyrosine in the diabetic plasma: evidence of oxidative stress

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3872226

Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3872226

Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3872226

On glomerular structural alterations in type-1 diabetes. Companions of early diabetic glomerulopathy

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3872226

Evidence that an angiotensin-converting enzyme inhibitor has a different effect on glomerular injury according to the different phase of the disease at which the treatment is started

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3872226

Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes

5 November 2018

1 reference

12 December 2020

Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism

1 reference

12 December 2020

Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes

1 reference

12 December 2020

A polymorphism in the gene for the endothelial nitric oxide synthase and diabetic nephropathy

1 reference

12 December 2020

Post-cyclosporine-mediated hypertension and nephropathy: amelioration by vascular endothelial growth factor

1 reference

12 December 2020

Allele A in intron 4 of ecNOS gene will not increase the risk of diabetic nephropathy in type 2 diabetes of Chinese population

1 reference

12 December 2020

Nitric oxide synthase gene polymorphisms and diabetic nephropathy

1 reference

12 December 2020

Morphometric investigations on intrarenal vessels of streptozotocin-diabetic rats

1 reference

12 December 2020

The impact of experimental diabetes mellitus in rats on glomerular capillary number and sizes

1 reference

12 December 2020

Three-dimensional analysis of increased vasculature around the glomerular vascular pole in diabetic nephropathy

1 reference

12 December 2020

Expression of vascular endothelial growth factor in renal vascular disease and renal allografts

1 reference

12 December 2020

Expression of vascular permeability factor (VPF/VEGF) is altered in many glomerular diseases

1 reference

12 December 2020

Heterogeneous nature of microalbuminuria in NIDDM: studies of endothelial function and renal structure

1 reference

12 December 2020

Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy

1 reference

12 December 2020

Vascular endothelial growth factor gene expression is correlated with glomerular neovascularization in human diabetic nephropathy

1 reference

12 December 2020

2-(8-hydroxy-6-methoxy-1-oxo-1h-2-benzopyran-3-yl) propionic acid, an inhibitor of angiogenesis, ameliorates renal alterations in obese type 2 diabetic mice

1 reference

12 December 2020

Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy

1 reference

12 December 2020

Identifiers

DOI

10.1155/2013/184539

1 reference

30 August 2017

1 reference

30 August 2017

1 reference

PMCID

3872226